A

American Well Corporation (AMWL)

NYQ – Real vaqt narxi. Valyuta: USD

7.89

-0.26 (-3.19%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

A

American Well Corporation (AMWL)

NYQ – Real vaqt narxi. Valyuta: USD

7.89

-0.26 (-3.19%)

Yopilishda: May 12, 2026, 4:00 PM EDT

11.05.2026

Amwell® to Participate in Upcoming Investor Conference

BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschhorn, CFO and COO, will participate in the 21st Annual Needham Technology, Media & Consumer Conference, taking place virtually on May 14, including a presentation at 2:15 p.m. ET. An audio webcast of the fireside chat will be available at investors.amwell.com.

11.05.2026

Hims & Hers Expands Digital Healthcare Platform via New Care Offerings

HIMS broadens its digital health platform with Labs, menopause and testosterone care, global acquisitions and a Novo Nordisk GLP-1 tie-up.

08.05.2026

American Well (AMWL) Upgraded to Buy: Here's What You Should Know

American Well (AMWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

08.05.2026

Despite Fast-paced Momentum, American Well (AMWL) Is Still a Bargain Stock

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, American Well (AMWL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

06.05.2026

American Well Corporation (AMWL) Q1 2026 Earnings Call Transcript

06.05.2026

American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates

American Well Corporation (AMWL) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to a loss of $1.73 per share a year ago.

05.05.2026

Amwell® Announces Results for First Quarter 2026

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the first quarter ended March 31, 2026. The company's first quarter earnings report can be viewed at investors.amwell.com.

Videolar

No Data

There is no data to display

Press-relizlar

05.05.2026

Amwell® Announces Results for First Quarter 2026

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the first quarter ended March 31, 2026. The company's first quarter earnings report can be viewed at investors.amwell.com.

18.02.2026

Amwell makes grant to new employee under inducement plan

BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announced that on February 18, Amwell made a grant of RSUs of 61,559 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee's employment with Amwell. The RSUs will vest as follows, subject to the employee's continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date (“Initial Vesting Date”), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date) for three years until such RSUs are vested in full.

12.02.2026

Amwell® Announces Results for Fourth Quarter and Full Year 2025

BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2025. The company's fourth quarter and full year 2025 earnings report can be viewed at investors.amwell.com.

04.11.2025

Amwell® Announces Results for Third Quarter 2025

BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the third quarter ended September 30. The company's third quarter earnings report may be viewed at investors.amwell.com.

Search stocks

American Well Corporation (AMWL)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

American Well Corporation (AMWL)

Amwell® to Participate in Upcoming Investor Conference

Hims & Hers Expands Digital Healthcare Platform via New Care Offerings

American Well (AMWL) Upgraded to Buy: Here's What You Should Know

Despite Fast-paced Momentum, American Well (AMWL) Is Still a Bargain Stock

American Well Corporation (AMWL) Q1 2026 Earnings Call Transcript

American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates

Amwell® Announces Results for First Quarter 2026

Videolar

No Data

Press-relizlar

Amwell® Announces Results for First Quarter 2026

Amwell makes grant to new employee under inducement plan

Amwell® Announces Results for Fourth Quarter and Full Year 2025

Amwell® Announces Results for Third Quarter 2025